Anixa Biosciences financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$0.49M $0.44M $0.51M $0.49M $2.06M $1.06M $0.73M $1.00M $0.94M $0.39M $3.67M $0.26M $0.30M $0.36M $1.11M $0.25M $0.00M $0.51M $0.00M $0.21M $0.00M
GM % Gross Margin %
64.38% -63.63% 69.24% 67.06% 95.37% 93.78% 88.74% 96.60% 100.00% 46.58% 61.48% 42.09% 62.94% 71.16% 30.93% 33.50% 0.00% 24.88% 0.00% 23.33% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% 0.00% -290.31% 0.00% 0.00% 0.00% 0.00% 0.00% -121.85% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share
$-0.76 $-0.57 $-0.44 $-0.45 $-0.45 $-0.32 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
0m 3.39m 3.63m 3.88m 4.21m 5.26m 5.75m 6.07m 6.98m 7.39m 8.3m 8.79m 8.72m 8.75m 16.56m 18.7m 20.21m 23.79m 29.95m 30.66m 31.07m
OCF Operating Cash Flow
$-1.21M $-1.72M $-1.85M $-2.40M $-0.90M $-2.50M $-2.41M $-0.72M $-3.14M $-3.19M $-2.38M $1.36M $-3.38M $-3.80M $-4.27M $-4.74M $-6.18M $-4.94M $-6.49M $-6.21M $0.00M
FCF Free Cash Flow
$-1.23M $0.00M $-1.86M $-2.41M $-0.91M $0.00M $0.00M $-0.73M $0.00M $0.00M $-2.39M $1.31M $-3.53M $-3.83M $-4.31M $-4.92M $-6.20M $0.00M $-13.35M $0.00M $0.00M
FCFS Free Cash Flow Per Share
$-0.37 $-0.49 $-0.49 $-0.58 $-0.18 $-0.45 $-0.41 $-0.11 $-0.43 $-0.41 $-0.27 $0.15 $-0.40 $-0.31 $-0.24 $-0.25 $-0.28 $-0.17 $-0.21 $-0.20 $0.00